Advertisement
UK markets close in 3 hours 36 minutes
  • FTSE 100

    8,115.37
    +36.51 (+0.45%)
     
  • FTSE 250

    19,815.39
    +213.41 (+1.09%)
     
  • AIM

    755.22
    +2.10 (+0.28%)
     
  • GBP/EUR

    1.1673
    +0.0017 (+0.14%)
     
  • GBP/USD

    1.2513
    +0.0002 (+0.01%)
     
  • Bitcoin GBP

    51,326.14
    +304.91 (+0.60%)
     
  • CMC Crypto 200

    1,384.61
    -11.92 (-0.85%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.04
    +0.47 (+0.56%)
     
  • GOLD FUTURES

    2,357.50
    +15.00 (+0.64%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,049.80
    +132.52 (+0.74%)
     
  • CAC 40

    8,038.77
    +22.12 (+0.28%)
     

How Is Novo Nordisk Positioned before 1Q18?

How Is Novo Nordisk Positioned before 1Q18?

In 4Q17, Novo Nordisk (NVO) generated revenues of 28 billion Danish kroner, which is a ~2% decline on a YoY (year-over-year) basis.